FacebookTwitterLinkedIn
Read More

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide

Rosenstock J, Sorli CH, Trautmann ME, Morales C, Wendisch U, Dailey G, Hompesch M, Choi IY, Kang J, Stewart J, Yoon KH
Diabetes Care. 2019 Jul 18. pii: dc182648. doi: 10.2337/dc18-2648. [Epub ahead of print]
Read More

Body weight management and safety with efpeglenatide in adults without diabetes: A phase II randomized study

Pratley RE, Kang J, Trautmann ME, Hompesch M, Han O, Stewart J, Sorli CH, Jacob S, Yoon KH
Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13824. [Epub ahead of print]
Read More

Sotagliflozin Decreases Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption

Powell D, Zambrowicz B, Morrow L, Beysen C, Hompesch M, Turner S, Hellerstein M, Banks P, Strumph P, Lapuerta P.
Presentation at the Endocrine Society Annual Meeting, New Orleans, LA. 2019 Mar 25.
Read More

Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes

Hompesch M, Patel DK, LaSalle JR, Bolli GB
Postgrad Med. 2019 Jan 29. doi: 10.1080/00325481.2019.1568136.
Read More

Relationship Between Controlled Attenuation Parameter (CAP) and Magnetic Resonance Imaging-Derived Proton Density Fat Fraction (MRI-PDFF) in Subjects at High Risk for Nonalcoholic Fatty Liver Disease (NAFLD)

Heidi Guthrie, Natalia Castro, Carine Beysen, Linda Morrow and Marcus Hompesch
Poster presented at the NASH-TAG Conference, Park City, UT. 2019 Jan 3-5.
Read More

Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.

Skrtic S, Tyrberg B, Broberg M, Ericsson H, Schnecke V, Kjaer M, Hompesch M, Andersson EM, Ryberg E, Aivazidis A, Wennberg Huldt C, Löfgren L, Morrow L, Parkinson J, Rydén-Bergsten T, Watkins E, Sörhede Winzell M.
PLoS One. 2018 Dec 17;13(12):e0208998. doi: 10.1371/journal.pone.0208998.
Read More

Pathophysiology of cardiovascular disease in diabetes mellitus.

Rodriguez-Araujo G, Nakagami H.
Cardiovascular Endocrinology & Metabolism 2018, 7:4–9
Read More

Application of a non-invasive integrated screening algorithm to improve enrollment in NAFLD/NASH clinical trials.

Rodriguez-Araujo G, Hernandez M, Morrow L, Millán L, Martínez-Arranz I, Hompesch M.
American Diabetes Association Scientific Sessions. 2018 June 22-25.
See More...
in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?

I'm interested in receiving: